First scientific publication

Preliminary research results, supported by the EU-funded project NANOFACTS, from the Horizon2020 program are published. We have successfully prepared silica nanoparticles for on-demand pH-responsive drug release in a weakly acidic tumor microenvironment. These  novel materials have been tested for cancer treatment on cancer cells in vitro and recently published in the journal Pharmaceutics.

Find out more at